Colonic Ewing Sarcoma/PNET associated with liver metastases: A systematic review and case report.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 07 10 2018
revised: 25 11 2018
accepted: 27 11 2018
pubmed: 17 12 2018
medline: 23 3 2019
entrez: 17 12 2018
Statut: ppublish

Résumé

Ewing Sarcoma is a highly lethal undifferentiated tumor of bone. ES is a small round cell tumor with etiological and characteristic chromosomal translocations between TET/FET (TLS/FUS, EWSR1, and TAF15) and ETS (E26 transformation-specific) family genes. Generally, therapeutic approach for metastatic Ewing Sarcoma includes both local (surgery and radiotherapy) and systemic (chemotherapy) disease control with an overall cure rate of 20%. For extra-osseous tumors, the most common primary sites of disease are trunk, extremities, head and neck, retroperitoneum. Among other sites, Ewing Sarcoma/PNET may also rarely arise in colon and rectum. Even if colonic Ewing Sarcoma/PNET have been previously reported in 5 cases, none of those reports came from right side of the colon. In this article, we report the first case of right-sided Ewing Sarcoma with synchronous liver metastases completely responding to first line chemotherapy. Furthermore, we provide a systematic qualitative review of the current literature on adult colorectal Ewing Sarcoma using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).

Identifiants

pubmed: 30553605
pii: S0344-0338(18)31365-7
doi: 10.1016/j.prp.2018.11.021
pii:
doi:

Types de publication

Case Reports Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

387-391

Informations de copyright

Copyright © 2018. Published by Elsevier GmbH.

Auteurs

Pietro Parcesepe (P)

Department of Diagnostics and Public Health - Section of Pathology, University and Hospital Trust of Verona, Verona 37134, Italy. Electronic address: parcesepe.pietro@gmail.com.

Guido Giordano (G)

Fondazione IRCCS Casa Sollievo della Sofferenza, UO di Oncologia Medica, 71013 San Giovanni Rotondo, Foggia, Italy. Electronic address: giordano.guido81@gmail.com.

Caterina Zanella (C)

Pathology Unit, ULSS9 "Scaligera", 37122 Verona, Italy. Electronic address: caterina.zanella@aulss9.veneto.it.

Jacopo Giuliani (J)

Oncology Unit, ULSS9 "Scaligera", 37122 Verona, Italy. Electronic address: jacopo.giuliani@aulss9.veneto.it.

Filippo Greco (F)

Oncology Unit, ULSS9 "Scaligera", 37122 Verona, Italy. Electronic address: filippo.greco@aulss9.veneto.it.

Andrea Bonetti (A)

Oncology Unit, ULSS9 "Scaligera", 37122 Verona, Italy. Electronic address: andrea.bonetti@aulss9.veneto.it.

Massimo Pancione (M)

Department of Sciences and Technologies, University of Sannio, 82100 Benevento, Italy. Electronic address: massimo.pancione@unisannio.it.

Erminia Manfrin (E)

Department of Diagnostics and Public Health - Section of Pathology, University and Hospital Trust of Verona, Verona 37134, Italy. Electronic address: erminia.manfrin@univr.it.

Enrico Molinari (E)

Surgery Unit, ULSS9 "Scaligera", 37122 Verona, Italy. Electronic address: enrico.molinari@aulss9.veneto.it.

Tiziana Pia Latiano (TP)

Fondazione IRCCS Casa Sollievo della Sofferenza, UO di Oncologia Medica, 71013 San Giovanni Rotondo, Foggia, Italy. Electronic address: latiano.tiziana@gmail.com.

Mario Rosario D'Andrea (MR)

Medical Oncology Unit, San Filippo Neri Hospital - ASL Roma 1, 00135, Roma, Italy. Electronic address: mariorosario.dandrea@aslroma1.it.

Matteo Fassan (M)

Department of Medicine (DIMED), University of Padua, 35121, Padova, Italy. Electronic address: matteo.fassan@unipd.it.

Nunzio Olivieri (N)

Department of Biology, University of Naples, Federico II, 80134 Napoli, Italy. Electronic address: n.olivieri@studenti.unina.it.

Andrea Remo (A)

Mater Salutis" Hospital, ULSS9, 37045 Legnago, Verona, Italy. Electronic address: remino76@yahoo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH